Avantax Planning Partners’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-121	Closed	-$3K	–	1364
2018 Q3	$3K	Buy	+121	New	+$3K	﹤0.01%	1301
2018 Q2	–	Sell	-157	Closed	-$5K	–	1705
2018 Q1	$5K	Buy	+157	New	+$5K	﹤0.01%	1379